Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine, often causing bouts of cramping, abdominal pain, bloating, diarrhea and constipation.

What is Irritable Bowel Syndrome?

Irritable bowel syndrome, commonly called IBS, is a chronic condition affecting the gastrointestinal system.

Symptoms of Irritable Bowel Syndrome

Causes of Irritable Bowel Syndrome

Diagnosis of Irritable Bowel Syndrome

Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) Prognosis

Irritable Bowel Syndrome (IBS) Epidemiology

Irritable Bowel Syndrome (IBS) and Infections

Irritable Bowel Syndrome (IBS) and Fibromyalgia

Irritable Bowel Syndrome (IBS) and Exercise

Irritable Bowel Syndrome (IBS) Food Triggers

Irritable Bowel Syndrome (IBS) and Psychiatric Illness

See more featured articles »

Irritable Bowel Syndrome (IBS) and Stress Response

Irritable Bowel Syndrome (IBS) and Diet

Mechanism of Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) Research

Irritable Bowel Syndrome (IBS) Comorbidities

Irritable Bowel Syndrome (IBS) Differential Diagnosis

Irritable Bowel Syndrome (IBS) Psychological Therapies

Self-Help for Irritable Bowel Syndrome (IBS)

High FODMAP Foods and Low FODMAP Food Alternatives

FODMAPs and Irritable Bowel Syndrome (IBS)

Post-Infectious Irritable Bowel Syndrome

New Biomarkers Discovered for IBS

Latest Irritable Bowel Syndrome News and Research

Gut-friendly psychobiotics could brighten moods and fight depression

Review uncovers that psychobiotics may offer supportive treatment for depression by restoring gut microbiome balance and positively influencing the microbiome-gut-brain axis, which is crucial for mental health and well-being.

8 Apr 2024

Irritable bowel syndrome not linked to higher Parkinson's risk, study finds

Research investigates the association between irritable bowel syndrome (IBS) and Parkinson's disease (PD), revealing that IBS is not linked to an increased overall risk of PD. Subgroup analyses suggest that certain IBS populations may have a lower risk of developing PD.

31 Mar 2024

Joint hypermobility linked to longer COVID-19 recovery time

Study shows that individuals with generalized joint hypermobility have a 30% higher risk of not recovering from acute COVID-19, highlighting the need for tailored treatment and care.

20 Mar 2024

ACS urges people to be on the lookout for five potential warning signs of colorectal cancer

In the recent Cancer Facts & Figures 2024 report from the American Cancer Society (ACS), researchers revealed a stark increase in colorectal cancer (CRC) incidence among Americans under the age of 55.

14 Mar 2024

Study links ultra-processed foods to gut health risks

A review in Nature Reviews Gastroenterology & Hepatology synthesizes evidence on the negative impacts of ultra-processed foods and food additives on gut health, linking them to chronic diseases and alterations in the gut microbiome.

25 Feb 2024

AGA guideline endorses fecal microbiota transplant as treatment for recurrent C. diff infection

In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

21 Feb 2024

Does your lifestyle increase your risk of IBS?

The relationship between healthy lifestyle behaviors and the incidence of IBS.

21 Feb 2024

Adopting key healthy behaviors reduces risk of irritable bowel syndrome

Adopting a healthy lifestyle is strongly linked to a lower risk of irritable bowel syndrome or IBS for short, finds research published online in the journal Gut.

20 Feb 2024

Missing gut microbes after antibiotics and a high-fat diet may be to blame for sugar-free candy and gum giving you gas

A recent Cell study showed how a high-fat diet and antibiotic exposure could trigger sorbitol intolerance by depleting Clostridia from the gut microbiota.

20 Feb 2024

Low FODMAP diet shows promise in IBS management, study finds nuanced benefits and challenges

Researchers review the low FODMAP diet's mechanisms in managing IBS, highlighting its efficacy and challenges in dietary implementation for symptom relief.

29 Jan 2024

Nutrigenomics paves the way for customized diets in lactose intolerance care

The current evidence on omics tools that allow for developing tailored nutrition strategies for individuals with lactose intolerance (LI).

24 Jan 2024

Is a gluten-free diet always the healthier choice for women?

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

23 Jan 2024

Receptor protein found to be a key player in prostate cancer cells' drug resistance

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.

22 Jan 2024

Migraine linked to increased risk of inflammatory bowel disease in new study

A nationwide cohort study reveals that individuals with migraine have a 1.3-fold higher risk of developing inflammatory bowel disease (IBD), suggesting a significant connection between migraine and IBD.

15 Jan 2024

Exploring the gut-brain link: How diet and nutrient absorption impact digestive disorders

The major disorders of gut-brain interactions (DGBIs).

8 Jan 2024

Study reveals treatment gaps and burden of symptoms among patients with microscopic colitis

It's a hidden cause of diarrhea and the development of the disease is poorly understood. Multiple factors work against the diagnosis of microscopic colitis, an inflammatory digestive disease, because the symptom distress compared to patients with other causes of chronic diarrhea remains unknown.

13 Dec 2023

Study explores the intricate gut-brain-liver connection and its impact on health

Study reviews the gut-brain-liver axis, revealing the complex interplay between these organs in health and disease and the implications for therapeutic interventions, focusing on how gut microbiota affects liver and brain health.

10 Dec 2023

Sympathetic nervous system and immune interplay: Key to metabolic regulation

A review in Advanced Science explores the interaction between the immune system and the sympathetic nervous system in regulating vital metabolic organs like the pancreas, liver, and adipose tissues. This comprehensive analysis provides insights into the neuroimmune relationships affecting metabolism, offering potential new therapeutic strategies for metabolic diseases.

5 Dec 2023

MSU researchers discover why inflammation in the gut causes visceral pain

Researchers at Michigan State University may have discovered why visceral pain is so common in people who have experienced inflammation in their guts, including patients with irritable bowel syndrome, or IBS.

21 Nov 2023

Cannabis shows promise in easing endometriosis pain, new research suggests

The Journal of Clinical Medicine review explores cannabis as a self-management strategy for endometriosis pain, revealing its potential to reduce gut inflammation and improve gut permeability, thereby alleviating bloating and suppressing pain through interactions with the endocannabinoid system and gut microbiota.

14 Nov 2023